These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8495257)

  • 41. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin.
    Tumiati B; Veneziani M; Bellelli A; Portioli I
    J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794
    [No Abstract]   [Full Text] [Related]  

  • 42. Longterm results of auranofin therapy.
    Bandilla KK; Missler B
    Clin Rheumatol; 1987 Sep; 6 Suppl 2():35-42. PubMed ID: 3690986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pyrithioxin and rheumatoid polyarthritis].
    Crouzet J; Beraneck L
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):45-8. PubMed ID: 3704512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An open study on the efficacy and safety of auranofin in treating psoriatic arthritis.
    Dequeker J; Gevers G
    Scand J Rheumatol Suppl; 1986; 63():85-95. PubMed ID: 3474779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin.
    Weinblatt ME; Polisson R; Blotner SD; Sosman JL; Aliabadi P; Baker N; Weissman BN
    Arthritis Rheum; 1993 May; 36(5):613-9. PubMed ID: 8489539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Injectable gold dermatitis and proteinuria: retreatment with auranofin.
    Tosi S; Cagnoli M; Guidi G; Murelli M; Messina K; Colombo B
    Int J Clin Pharmacol Res; 1985; 5(4):265-8. PubMed ID: 2932399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Auranofin or D-penicillamine in the treatment of rheumatoid arthritis.
    Hochberg MC
    Ann Intern Med; 1986 Oct; 105(4):528-35. PubMed ID: 3092712
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence and management of diarrhea during longterm auranofin therapy.
    Wallin BA; McCafferty JP; Fox MJ; Cooper DR; Goldschmidt MS
    J Rheumatol; 1988 Dec; 15(12):1755-8. PubMed ID: 3265956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic effect of pyritinol on sequelae of head injuries.
    Kitamura K
    J Int Med Res; 1981; 9(3):215-21. PubMed ID: 7016627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Squamous eruption of the lichen planus histological type during treatment with pyritinol].
    Méraud JP; géniaux M; Tamisier JM; Delaunay MM; Texier L
    Ann Dermatol Venereol; 1980 Jun; 107(6):561-4. PubMed ID: 7425461
    [No Abstract]   [Full Text] [Related]  

  • 51. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis.
    Felix-Davies DD; Stewart AM; Wilkinson BR; Bateman JR; Delamere JP
    Am J Med; 1983 Dec; 75(6A):138-41. PubMed ID: 6419596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment.
    Boiardi L; Macchioni P; Salvarani C; Rossi F; Casadei-Maldini M; Mancini R; Beltrandi E; Portioli I
    Clin Exp Rheumatol; 1994; 12(4):357-62. PubMed ID: 7955597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study].
    Klein G; Schwann H; Mirtl B; Thumb N; Mayerhofer F; Singer F; Tausch G; Gaismayer K; Rieder H; Hartweger A
    Z Rheumatol; 1988; 47(5):342-6. PubMed ID: 3149087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral gold therapy with auranofin (SK&F 39162). A multicenter open study in patients with rheumatoid arthritis.
    Bandilla K; Gross D; Gross W; Herrlinger JD; Kriegel W; Müller W; Siegmeth W; Tausch G; Thumb N; Wagenhäuser FJ
    J Rheumatol Suppl; 1982; 8():154-9. PubMed ID: 6813478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum phospholipase A2 activity in patients with rheumatoid arthritis before and after treatment with methotrexate, auranofin, or combination of the two.
    Michaels RM; Reading JC; Beezhold DH; Ward JR
    J Rheumatol; 1996 Feb; 23(2):226-9. PubMed ID: 8882023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
    Aletaha D; Bingham CO; Tanaka Y; Agarwal P; Kurrasch R; Tak PP; Popik S
    Lancet; 2017 Mar; 389(10075):1206-1217. PubMed ID: 28215362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study.
    Am J Med; 1995 Feb; 98(2):156-68. PubMed ID: 7847432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study.
    Emery P; Bingham CO; Burmester GR; Bykerk VP; Furst DE; Mariette X; van der Heijde D; van Vollenhoven R; Arendt C; Mountian I; Purcaru O; Tatla D; VanLunen B; Weinblatt ME
    Ann Rheum Dis; 2017 Jan; 76(1):96-104. PubMed ID: 27165179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The cost effectiveness of auranofin: results of a randomized clinical trial.
    Thompson MS; Read JL; Hutchings HC; Paterson M; Harris ED
    J Rheumatol; 1988 Jan; 15(1):35-42. PubMed ID: 3127585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.